 "Nifty outlook and top technical calls by HDFC Securities for today")
Nifty outlook and technical calls by Vinay Rajani Technical Analyst, HDFC Securities:
Nifty View
Nifty managed to hold above the previous week’s low of 10866 and recovered nicely, to close at 11067. Bank Nifty also recovered sharply on the back of short covering. Due to the oversold condition of many of the beaten-down stocks in large cap segment, the market witnessed a pullback rally. On the upside, Nifty has got resistance at 11170-11200. It would be advisable to hold Nifty longs with 10866 stop loss.
Buy BIOCON
CMP: Rs 701.55
Target: Rs. 740
Also Read
Stop-loss: Rs 675
The stock price has registered a new all-time high with significant volumes. The stock price has also broken out from last 8 month’s consolidation. Pharma Sector has also been outperforming. Oscillators are also showing bullish momentum for the stock. We recommend buying Biocon for the target of 740, keeping SL at 675.
Buy DIVIS LAB
CMP: Rs 1388
Target Rs. 1500
Stop-loss Rs 1328
The stock price has been hovering around its all time. Despite a heavy sell-off in the most of the stocks, Divis has been able to show resilient movement in the recent downswings in markets. Short term moving averages are trading above long-term moving averages, indicating a bullish trend. We recommend buying Divislab for the target of 1500, keeping SL at 1328.
Disclaimer: The analyst may have positions in any or all the stocks mentioned above.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%